Fully immunocompetent C57BL/6 and anti-CD4-treated C57BL/6 mice were markedly protected against reinfection (9, 11, 13), exhibiting a significant decrease in both bacterial shedding and duration of infection compared to primary infection (Fig. 3B). The gene discussed is CD4; the disease is infection.